Other Novel PET Radiotracers for Breast Cancer

PET Clin. 2023 Oct;18(4):557-566. doi: 10.1016/j.cpet.2023.05.001. Epub 2023 Jun 25.

Abstract

Many novel PET radiotracers have demonstrated potential use in breast cancer. Although not currently approved for clinical use in the breast cancer population, these innovative imaging agents may one day play a role in the diagnosis, staging, management, and even treatment of breast cancer.

Keywords: Breast cancer; FAPI; FLT; FMISO; Fluciclovine; ImmunoPET; PARP; PET/CT.

Publication types

  • Review

MeSH terms

  • Breast Neoplasms* / diagnostic imaging
  • Female
  • Humans
  • Positron Emission Tomography Computed Tomography / methods
  • Positron-Emission Tomography / methods
  • Radiopharmaceuticals

Substances

  • Radiopharmaceuticals